LCGC North America
This article describes the method development and performance characteristics of the validated LFI assay and evaluates stability in human plasma.
Laura Archer
Advertisement
Articles by Laura Archer
Advertisement
Latest Updated Articles
Quantifying an Anthrax LF Inhibitor in Human Plasma by HPLC-MS-MSFebruary 1st 2008
Advertisement
Advertisement
Trending on LCGC International
1
GC-MS/MS Links Tooth-Layer Pollutant Traces to Autism Risk
2
HTC-19 Insights: HPLC–XRF for Environmental Analysis — Future Developments
3
The Silent Crisis: Can The Demise of Chromatography Teaching in Universities Be Reversed?
4
HTC-19 Insights: Advancing HPLC–XRF for the Analysis of Brominated Flame Retardants and Other Pollutants
5